NextGen Healthcare, Inc. (NXGN): Price and Financial Metrics
NextGen Healthcare, Inc. (NXGN)
Today's Latest Price: $10.62 USD
Updated Jun 3 2:54pm
Add NXGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
NXGN Stock Summary
- With a price/earnings ratio of 43.95, Nextgen Healthcare Inc P/E ratio is greater than that of about 82.61% of stocks in our set with positive earnings.
- With a year-over-year growth in debt of 220.81%, Nextgen Healthcare Inc's debt growth rate surpasses 92.82% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Nextgen Healthcare Inc is reporting a growth rate of 175.3%; that's higher than 93.05% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Nextgen Healthcare Inc are IRBT, CPSI, MBII, TTPH, and GIGA.
- NXGN's SEC filings can be seen here. And to visit Nextgen Healthcare Inc's official web site, go to www.nextgen.com.
NXGN Stock Price Chart More Charts
NXGN Price/Volume Stats
| Current price | $10.62 | 52-week high | $20.68 |
| Prev. close | $10.48 | 52-week low | $5.10 |
| Day low | $10.50 | Volume | 278,043 |
| Day high | $11.29 | Avg. volume | 404,339 |
| 50-day MA | $10.06 | Dividend yield | N/A |
| 200-day MA | $13.79 | Market Cap | 697.74M |
NextGen Healthcare, Inc. (NXGN) Company Bio
NextGen Healthcare (formerly Quality Systems) develops and markets computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. The company was founded in 1974 and is based in Irvine, California.
NXGN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $10.62 | $5.96 | -42% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Nextgen Healthcare Inc. To summarize, we found that Nextgen Healthcare Inc ranked in the 33th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 42%. As for the metrics that stood out in our discounted cash flow analysis of Nextgen Healthcare Inc, consider:
- Interest coverage, a measure of earnings relative to interest payments, is 9.68 -- which is good for besting 70.32% of its peer stocks (US stocks in the Technology sector with positive cash flow).
- The company's compound free cash flow growth rate over the past 5.5 years comes in at -0.04%; that's greater than only 23.02% of US stocks we're applying DCF forecasting to.
- The business' balance sheet reveals debt to be 11% of the company's capital (with equity being the remaining amount). Approximately only 23.42% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -43% |
| 1% | -43% |
| 2% | -42% |
| 3% | -42% |
| 4% | -41% |
| 5% | -41% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as NXGN, try ADSK, FARO, KEYS, MEI, and SLAB.
Loading social stream, please wait...